These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Diabetes as a risk factor for Alzheimer's disease in the Middle East and its shared pathological mediators. Jayaraj RL; Azimullah S; Beiram R Saudi J Biol Sci; 2020 Feb; 27(2):736-750. PubMed ID: 32210695 [TBL] [Abstract][Full Text] [Related]
8. Rationale for a Multi-Factorial Approach for the Reversal of Cognitive Decline in Alzheimer's Disease and MCI: A Review. Rao RV; Subramaniam KG; Gregory J; Bredesen AL; Coward C; Okada S; Kelly L; Bredesen DE Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675177 [TBL] [Abstract][Full Text] [Related]
9. Multidomain Lifestyle Intervention Strategies for the Delay of Cognitive Impairment in Healthy Aging. Toman J; Klímová B; Vališ M Nutrients; 2018 Oct; 10(10):. PubMed ID: 30347863 [TBL] [Abstract][Full Text] [Related]
10. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics. Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754 [TBL] [Abstract][Full Text] [Related]
11. Linking Cerebrovascular Dysfunction to Age-Related Hearing Loss and Alzheimer's Disease-Are Systemic Approaches for Diagnosis and Therapy Required? Förster CY; Shityakov S; Scheper V; Lenarz T Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421731 [TBL] [Abstract][Full Text] [Related]
12. Molecular and Cellular Basis of Neurodegeneration in Alzheimer's Disease. Jeong S Mol Cells; 2017 Sep; 40(9):613-620. PubMed ID: 28927263 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade. Honjo K; Black SE; Verhoeff NP Can J Neurol Sci; 2012 Nov; 39(6):712-28. PubMed ID: 23227576 [TBL] [Abstract][Full Text] [Related]
14. Effects of multidomain lifestyle interventions on cognitive decline and Alzheimer's disease prevention: A literature review and future recommendations. Noach S; Witteman B; Boss HM; Janse A Cereb Circ Cogn Behav; 2023; 4():100166. PubMed ID: 37215433 [TBL] [Abstract][Full Text] [Related]
15. Subregional Density of Neurons, Neurofibrillary Tangles and Amyloid Plaques in the Hippocampus of Patients With Alzheimer's Disease. Furcila D; Domínguez-Álvaro M; DeFelipe J; Alonso-Nanclares L Front Neuroanat; 2019; 13():99. PubMed ID: 31920568 [TBL] [Abstract][Full Text] [Related]
16. Is Beta-Amyloid Accumulation a Cause or Consequence of Alzheimer's Disease? Wang S; Mims PN; Roman RJ; Fan F J Alzheimers Parkinsonism Dement; 2016; 1(2):. PubMed ID: 28815226 [TBL] [Abstract][Full Text] [Related]
17. Key brain cell interactions and contributions to the pathogenesis of Alzheimer's disease. Saavedra J; Nascimento M; Liz MA; Cardoso I Front Cell Dev Biol; 2022; 10():1036123. PubMed ID: 36523504 [TBL] [Abstract][Full Text] [Related]
18. Exploring the dual character of metformin in Alzheimer's disease. Ning P; Luo A; Mu X; Xu Y; Li T Neuropharmacology; 2022 Apr; 207():108966. PubMed ID: 35077762 [TBL] [Abstract][Full Text] [Related]
19. Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment. McMaster M; Kim S; Clare L; Torres SJ; D'Este C; Anstey KJ Clin Interv Aging; 2018; 13():2397-2406. PubMed ID: 30538436 [TBL] [Abstract][Full Text] [Related]